← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV20행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTPhase 2
L-Asparaginase (L-Asparaginase)
Genentech, Inc.·B Lymphoblastic Leukemia
58 trials
Overview
Program
L-Asparaginase
Overview
Company
Genentech, Inc.
Overview
Modality
CGT
Overview
Target
B Lymphoblastic Leukemia
Overview
Indication
B Lymphoblastic Leukemia
Overview
Phase
PHASE_2
Overview
Status
RECRUITING
MoA
Mechanism
target of rapamycin (mTOR), the other major amino acid-sensing pathway
MoA
Biomarker
biomarkers
PK/PD
Species
Mouse, Human
PK/PD
Animal (cat.)
Human, Mouse, In vitro
PK/PD
Experiment
PK
Toxicology
Species
Mouse, Human
Toxicology
Animal (cat.)
Human, Mouse, In vitro
Toxicology
Major finding
Pleurotus ostreatus L-asparaginase's use in food safety and biotechnology: from processing assistance to bioactive agent.. L-ASNase has attracted attention in many biomedical and food safety applications. Therefore, this study was designed to identify a novel and promising candidate for the sustainable biosynthesis of extracellular L-ASNase from P. ostreatus AUMC 16015 grown on various agricu…
Clinical
OS
33.6
Clinical
Result source
ClinicalTrials.gov NCT00061945
Clinical
Data Tier / Score
A · 38
Clinical
Program phase
PHASE_2
Clinical
Clinical sync
2026년 7월 13일 (1일 전)